CALCIUM GLUCONATE IN SODIUM CHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Calcium Gluconate In Sodium Chloride, and when can generic versions of Calcium Gluconate In Sodium Chloride launch?
Calcium Gluconate In Sodium Chloride is a drug marketed by Fresenius Kabi Usa and Hq Spclt Pharma and is included in two NDAs. There are two patents protecting this drug.
The generic ingredient in CALCIUM GLUCONATE IN SODIUM CHLORIDE is calcium gluconate. There are two hundred and eighty-two drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the calcium gluconate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Calcium Gluconate In Sodium Chloride
A generic version of CALCIUM GLUCONATE IN SODIUM CHLORIDE was approved as calcium gluconate by FRESENIUS KABI USA on June 15th, 2017.
Summary for CALCIUM GLUCONATE IN SODIUM CHLORIDE

Recent Clinical Trials for CALCIUM GLUCONATE IN SODIUM CHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Ascension Genesys Hospital | Phase 2 |
Aurora Health Care | Phase 4 |
First Affiliated Hospital Xi'an Jiaotong University | N/A |
See all CALCIUM GLUCONATE IN SODIUM CHLORIDE clinical trials
Pharmacology for CALCIUM GLUCONATE IN SODIUM CHLORIDE
Drug Class | Blood Coagulation Factor Phosphate Binder |
Mechanism of Action | Phosphate Chelating Activity |
Physiological Effect | Increased Coagulation Factor Activity |
Anatomical Therapeutic Chemical (ATC) Classes for CALCIUM GLUCONATE IN SODIUM CHLORIDE
US Patents and Regulatory Information for CALCIUM GLUCONATE IN SODIUM CHLORIDE
CALCIUM GLUCONATE IN SODIUM CHLORIDE is protected by two US patents.
Patents protecting CALCIUM GLUCONATE IN SODIUM CHLORIDE
Calcium gluconate solutions in flexible containers
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Calcium gluconate solutions in flexible containers
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial